首页 » 细胞株Cell Lines 101及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 101及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV101
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

http://www.biovector.net


ID   SYF + c-Src

AC   CVCL_8976

DR   CLO; CLO_0009234

DR   ATCC; CRL-2498

RX   PubMed=10228160;

CC   Knockout cell: Method=KO mouse; MGI; MGI:95602; Fyn.

CC   Knockout cell: Method=KO mouse; MGI; MGI:98397; Src.

CC   Knockout cell: Method=KO mouse; MGI; MGI:99147; Yes1.

CC   Transfected with: MGI; MGI:98397; Src.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6461 ! SYF

CA   Transformed cell line

//

ID   SYM-I

AC   CVCL_M718

RX   PubMed=6208314;

CC   From: Sekiguchi M.; Institute of Medical Science; University of Tokyo; Tokyo; Japan.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SYN-1

AC   CVCL_W498

RX   PubMed=12237927;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SYNb-1

AC   CVCL_W499

RX   PubMed=12237927;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W500 ! SYNb-2

SX   Male

CA   Cancer cell line

//

ID   SYNb-2

AC   CVCL_W500

RX   PubMed=12237927;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W499 ! SYNb-1

SX   Male

CA   Cancer cell line

//

ID   SYO-1

AC   CVCL_7146

SY   SYO-I

DR   Cosmic; 1211854

DR   Cosmic; 1319812

DR   Cosmic; 2307725

DR   GEO; GSM482570

DR   GEO; GSM1676335

DR   GEO; GSM1701667

RX   PubMed=14744540;

RX   PubMed=24726063;

RX   PubMed=26351324;

DI   NCIt; C4279; Biphasic synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SYSU-1

AC   CVCL_C067

SY   SYSUe001-A

DR   hPSCreg; SYSUe001-A

DR   ISCR; 1600

RX   PubMed=17442208;

CC   From: Sun Yat-sen University; Guangzhou; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SYSU-2

AC   CVCL_C068

SY   SYSUe002-A

DR   hPSCreg; SYSUe002-A

DR   ISCR; 1601

RX   PubMed=17442208;

CC   From: Sun Yat-sen University; Guangzhou; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-32

AC   CVCL_M633

SY   sz-32; CHL-5

DR   IMGT/HLA; 16475

RX   PubMed=19845917;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SZ-BOR1

AC   CVCL_Y322

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C98983; Melnick-Fraser syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-BRCA1

AC   CVCL_Y323

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C36100; BRCA1 syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-CIPA1

AC   CVCL_Y324

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C118633; Congenital insensitivity to pain with anhidrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-DM1

AC   CVCL_Y325

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SZ-DM2

AC   CVCL_Y326

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-DM4

AC   CVCL_Y327

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-DM5

AC   CVCL_Y328

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SZ-DM7

AC   CVCL_Y329

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84679; Dystrophia myotonica 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-FX1

AC   CVCL_Y330

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-FX10

AC   CVCL_Y331

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-FX2

AC   CVCL_Y332

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SZ-FX3

AC   CVCL_Y333

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-FX5

AC   CVCL_Y334

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-FX6

AC   CVCL_Y335

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C84717; Fragile X syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SZ-HED7

AC   CVCL_Y336

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SZ-Hun4

AC   CVCL_Y337

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C61260; Hunter syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-Rb18

AC   CVCL_Y338

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   SZ-Rb2

AC   CVCL_Y339

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-Rb26

AC   CVCL_Y340

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ-SBMA

AC   CVCL_Y341

RX   PubMed=21585244;

CC   From: Shaare Zedek Medical Center; The Hebrew University; Jerusalem; Israel.

DI   NCIt; C85233; X-linked bulbar-muscular atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SZ95

AC   CVCL_9803

SY   SZ-95; SZ 95

DR   BTO; BTO:0003484

RX   PubMed=10594745;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SZGSQ-12

AC   CVCL_9T35

DR   IMGT/HLA; 25445

RX   PubMed=22077627;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   T HESCs

AC   CVCL_C464

SY   THESCs

DR   ATCC; CRL-4003

DR   BioSample; SAMN03471714

RX   PubMed=14726435;

CC   Transfected with: HGNC; 11730; TERT.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12,13

ST   D16S539: 12,14

ST   D5S818: 8

ST   D7S820: 10

ST   TH01: 7,8

ST   TPOX: 9,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   T 174

AC   CVCL_U955

DR   ATCC; CRL-7726

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7726; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 10,11

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 18

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T-1

AC   CVCL_M858

DR   BioSample; SAMN03151761

RX   CelloPub=CLPUB00262;

RX   PubMed=7394535;

RX   PubMed=13545791;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=7394535, PubMed=20143388). Originally thought to originate from the kidney of a 8-year old boy.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   T-1387

AC   CVCL_F244

DR   CLO; CLO_0009240

DR   CLDB; cl4453

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/human/ht-1387.htm

DI   NCIt; C3183; T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T-23

AC   CVCL_5595

DR   CLO; CLO_0050007

DR   RCB; RCB1861

RX   PubMed=3331674;

OX   NCBI_TaxID=37347; ! Tupaia belangeri

SX   Male

CA   Finite cell line

//

ID   T-23 clone 8

AC   CVCL_5596

SY   T-238

DR   JCRB; JCRB0745

OX   NCBI_TaxID=37347; ! Tupaia belangeri

HI   CVCL_5595 ! T-23

SX   Male

CA   Finite cell line

//

ID   T-289

AC   CVCL_8760

SY   289

DR   BTO; BTO:0004618

RX   PubMed=3652009;

RX   PubMed=8752169;

RX   PubMed=10661763;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T-3-Cl-2

AC   CVCL_4312

AS   CVCL_F515

SY   T-3-CI-2; T3-C12; T3-CI2; T3Cl2; T3CL2; GM00979

DR   CLO; CLO_0029501

DR   Coriell; GM00979

RX   PubMed=1071084;

RX   PubMed=4509323;

CC   Breed/subspecies: DDD.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1N76 ! TSFAT-3

SX   Male

CA   Cancer cell line

//

ID   T-3-Cl-2-0.fl

AC   CVCL_4313

SY   T-3-CI-2-0.fl

DR   CLO; CLO_0050784

DR   ECACC; 99072804

DR   RCB; RCB0561

CC   Breed/subspecies: DDD.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4312 ! T-3-Cl-2

SX   Male

CA   Cancer cell line

//

ID   T-33

AC   CVCL_8427

DR   BioSample; SAMN03151816

RX   PubMed=3167860;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0004 ! K-562

SX   Female

CA   Cancer cell line

//

ID   T-47

AC   CVCL_3945

SY   T47

DR   BTO; BTO:0003741

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T-47D

AC   CVCL_0553

SY   T-47-D; T47-D; T47D:A; T47D

DR   BTO; BTO:0001248

DR   CLO; CLO_0009251

DR   EFO; EFO_0001247

DR   MCCL; MCC:0000454

DR   CLDB; cl4454

DR   CLDB; cl4455

DR   CLDB; cl4923

DR   ATCC; HTB-133

DR   BCRC; 60250

DR   BCRJ; 0323

DR   BioSample; SAMN03472872

DR   CCLE; T47D_BREAST

DR   CCRID; 3111C0001CCC000265

DR   CCRID; 3131C0001000700087

DR   CCRID; 3142C0001000000045

DR   ChEMBL-Cells; CHEMBL3307606

DR   ChEMBL-Targets; CHEMBL614361

DR   CLS; 300353/p525_T-47D

DR   Cosmic; 687500

DR   Cosmic; 755296

DR   Cosmic; 871150

DR   Cosmic; 875882

DR   Cosmic; 877451

DR   Cosmic; 894091

DR   Cosmic; 897428

DR   Cosmic; 904395

DR   Cosmic; 905945

DR   Cosmic; 934538

DR   Cosmic; 944295

DR   Cosmic; 947353

DR   Cosmic; 949193

DR   Cosmic; 979711

DR   Cosmic; 991330

DR   Cosmic; 997925

DR   Cosmic; 1000126

DR   Cosmic; 1010918

DR   Cosmic; 1017169

DR   Cosmic; 1018470

DR   Cosmic; 1019311

DR   Cosmic; 1027050

DR   Cosmic; 1044203

DR   Cosmic; 1044220

DR   Cosmic; 1046942

DR   Cosmic; 1047715

DR   Cosmic; 1092641

DR   Cosmic; 1136342

DR   Cosmic; 1152529

DR   Cosmic; 1175835

DR   Cosmic; 1176629

DR   Cosmic; 1287901

DR   Cosmic; 1289418

DR   Cosmic; 1305387

DR   Cosmic; 1308999

DR   Cosmic; 1312373

DR   Cosmic; 1434958

DR   Cosmic; 1524350

DR   Cosmic; 1565732

DR   Cosmic; 1603226

DR   Cosmic; 1609473

DR   Cosmic; 1995658

DR   Cosmic; 1998484

DR   Cosmic; 2162162

DR   Cosmic; 2165027

DR   Cosmic; 2301534

DR   Cosmic; 2318373

DR   Cosmic; 2437466

DR   Cosmic; 2564833

DR   Cosmic-CLP; 905945

DR   DSMZ; ACC-739

DR   ECACC; 85102201

DR   ENCODE; ENCBS323FFY

DR   ENCODE; ENCBS440ENC

DR   ENCODE; ENCBS441ENC

DR   ENCODE; ENCBS442ENC

DR   ENCODE; ENCBS597ENC

DR   ENCODE; ENCBS598ENC

DR   ENCODE; ENCBS599ENC

DR   ENCODE; ENCBS600ENC

DR   ENCODE; ENCBS601ENC

DR   ENCODE; ENCBS602ENC

DR   ENCODE; ENCBS603ENC

DR   ENCODE; ENCBS604ENC

DR   ENCODE; ENCBS610MSM

DR   ENCODE; ENCBS620AAA

DR   ENCODE; ENCBS622AAA

DR   ENCODE; ENCBS624AAA

DR   ENCODE; ENCBS625AAA

DR   ENCODE; ENCBS626AAA

DR   ENCODE; ENCBS627AAA

DR   ENCODE; ENCBS805DMB

DR   ENCODE; ENCBS943ULT

DR   GDSC; 905945

DR   GEO; GSM818

DR   GEO; GSM50185

DR   GEO; GSM50249

DR   GEO; GSM69196

DR   GEO; GSM73762

DR   GEO; GSM115116

DR   GEO; GSM149980

DR   GEO; GSM149988

DR   GEO; GSM149996

DR   GEO; GSM186461

DR   GEO; GSM186462

DR   GEO; GSM186463

DR   GEO; GSM217605

DR   GEO; GSM344358

DR   GEO; GSM344408

DR   GEO; GSM350514

DR   GEO; GSM378141

DR   GEO; GSM388215

DR   GEO; GSM459712

DR   GEO; GSM481305

DR   GEO; GSM559637

DR   GEO; GSM750782

DR   GEO; GSM783929

DR   GEO; GSM799322

DR   GEO; GSM799385

DR   GEO; GSM816673

DR   GEO; GSM827326

DR   GEO; GSM847440

DR   GEO; GSM847507

DR   GEO; GSM847164

DR   GEO; GSM844715

DR   GEO; GSM844714

DR   GEO; GSM844716

DR   GEO; GSM887685

DR   GEO; GSM888777

DR   GEO; GSM923428

DR   GEO; GSM923429

DR   GEO; GSM923431

DR   GEO; GSM923436

DR   GEO; GSM967820

DR   GEO; GSM1008576

DR   GEO; GSM1008919

DR   GEO; GSM1153391

DR   GEO; GSM1181243

DR   GEO; GSM1181259

DR   GEO; GSM1214577

DR   GEO; GSM1374950

DR   GEO; GSM1374951

DR   GEO; GSM1374952

DR   GEO; GSM1401654

DR   GEO; GSM1670521

DR   GEO; GSM1833628

DR   ICLC; HTL98003

DR   KCB; KCB 2011116YJ

DR   KCLB; 30133

DR   LINCS; 50541

DR   Lonza; 748

DR   NCBI_Iran; C203

DR   PRIDE; PXD002104

DR   SKY/M-FISH/CGH; 2824

DR   TOKU-E; 3260

DR   TOKU-E; 3775

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=228940;

RX   PubMed=2041050;

RX   PubMed=8824553;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=11414198;

RX   PubMed=12353263;

RX   PubMed=12661003;

RX   PubMed=12800145;

RX   PubMed=15767549;

RX   PubMed=17088437;

RX   PubMed=17157791;

RX   PubMed=17254797;

RX   PubMed=19372543;

RX   PubMed=19582160;

RX   PubMed=19727395;

RX   PubMed=20070913;

RX   PubMed=21378333;

RX   PubMed=22460905;

RX   PubMed=23325432;

RX   PubMed=23601657;

RX   PubMed=23671654;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=5

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/t-47d.htm

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=T-47D

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/T47D_StamandMyers_protocol.pdf

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=69

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-41.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 1.6 days (PubMed=9671407); 45.5 hours (DTP); ~30-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'T470' in Cosmic 877451 and Cosmic 1152529.

CC   Misspelling: 'T74D' in Cosmic 1027050.

CC   Misspelling: 'T-47D-RU' in Cosmic 1175835.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 28,31

ST   D2S1338: 24

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 23

ST   Penta D: 10,12

ST   Penta E: 7,14

ST   TH01: 6 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200)

ST   TH01: 6,7 (CLS)

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3945 ! T-47

SX   Female

CA   Cancer cell line

//

ID   T-47D SimpleCell O-GalNAc

AC   CVCL_S034

SY   T47D SimpleCell; T47D SC

RX   PubMed=23584533;

CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.

CC   Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T-47D Tet-On

AC   CVCL_V334

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T-47D-Luc

AC   CVCL_AS01

DR   JCRB; JCRB1374

DR   JCRB; NIHS0639

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; JCRB1374; probable.

CC   Discontinued: JCRB; NIHS0639; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 12,13

ST   D5S818: 13

ST   D7S820: 10,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T-47Daro

AC   CVCL_9582

RX   PubMed=9449203;

CC   Transfected with: HGNC; 2594; CYP19A1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T-88

AC   CVCL_5369

SY   T88

RX   PubMed=2624778;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=T88

CC   Characteristics: IL3 or IL5 dependent.

CC   Caution: Not from strain DBA/2J as originally published but from strain C3H/He (DOI 10.4051/ibc.2010.2.4.0014).

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Factor-dependent cell line

//

ID   T-9

AC   CVCL_M092

SY   T9

DR   BioSample; SAMN03151762

RX   PubMed=1246601;

RX   PubMed=4472134;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4472134, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   T-Ag-MOSE

AC   CVCL_C562

DR   JCRB; JCRB0151

DR   JCRB; NIHS0214

RX   PubMed=9820870;

CC   Discontinued: JCRB; NIHS0214; true.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   T-AL/N

AC   CVCL_6334

SY   T AL/N; TAL/N

DR   CLO; CLO_0009266

DR   ATCC; CRL-6514

RX   PubMed=174816;

RX   PubMed=4302577;

RX   PubMed=4331720;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6514; true.

CC   Breed/subspecies: AL/N.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6312 ! AL/N

CA   Spontaneously immortalized cell line

//

ID   T-HEECs

AC   CVCL_0F63

SY   T HEECs; THEECs

DR   ATCC; CRL-4026

DR   BioSample; SAMN03471729

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: ATCC; CRL-4026; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,10,12

ST   D16S539: 9,12

ST   D5S818: 11,12,13

ST   D7S820: 9,10,11,12

ST   TH01: 7,8,9

ST   TPOX: 8,10

ST   vWA: 14,15,18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   T-HSC/Cl-6

AC   CVCL_M083

DR   BTO; BTO:0003527

RX   PubMed=12753423;

RX   PubMed=17760834;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   t-HUE2

AC   CVCL_J427

RX   PubMed=1817644;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2029 ! ECV-304

SX   Female

CA   Cancer cell line

//

ID   t-HUE4

AC   CVCL_J428

RX   PubMed=1817644;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2029 ! ECV-304

SX   Female

CA   Cancer cell line

//

ID   T-REx-293

AC   CVCL_D585

SY   T-REx 293; HEK293-T-REx

DR   BTO; BTO:0005238

WW   http://www.thermofisher.com/order/catalog/product/R71007

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-410.html

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/T-REx-HEK293_Farnham_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   T-REx-CHO

AC   CVCL_D586

SY   T-REx CHO

WW   http://www.thermofisher.com/order/catalog/product/R71807

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-599.html

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0213 ! CHO

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T-REx-HeLa

AC   CVCL_D587

SY   T-REx HeLa; HeLa T-REx

DR   TOKU-E; 3542

WW   http://www.thermofisher.com/order/catalog/product/R71407

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-598.html

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   T-REx-Jurkat

AC   CVCL_D588

SY   T-REx Jurkat

WW   http://www.thermofisher.com/order/catalog/product/R72207

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0065 ! Jurkat

SX   Male

CA   Cancer cell line

//

ID   T-YFP-SF1

AC   CVCL_F703

RX   PubMed=21959845;

CC   Group: Cetacean cell line.

CC   Doubling time: 27.27 hours (in 15% FBS), 29.4 hours (in 10% FBS) (PubMed=21959845).

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Asiaeorientalis.

OX   NCBI_TaxID=34892; ! Neophocaena phocaenoides

HI   CVCL_F702 ! YFP-SF1

SX   Male

CA   Transformed cell line

//

ID   T.T

AC   CVCL_3174

SY   T-T; T_T_; T. T; tdott

DR   BioSample; SAMN03470960

DR   CCLE; TT_OESOPHAGUS

DR   Cosmic; 923184

DR   Cosmic-CLP; 1299064

DR   GDSC; 1299064

DR   GEO; GSM827520

DR   GEO; GSM887713

DR   GEO; GSM888806

DR   GEO; GSM1670549

DR   JCRB; JCRB0262

RX   DOI=10.5794/jjoms.36.307;

RX   PubMed=9290701;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 40 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Mandible.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 13,17

ST   D19S433: 14,15

ST   D21S11: 30

ST   D2S1338: 24

ST   D3S1358: 15

ST   D5S818: 8,10

ST   D7S820: 11

ST   D8S1179: 15,16

ST   FGA: 18

ST   Penta D: 12

ST   Penta E: 16,18

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T.Tn

AC   CVCL_3175

SY   T_Tn; T-Tn; TTn; T Tn; T-Tn6; TTN

DR   BioSample; SAMN03471669

DR   Cosmic; 873391

DR   Cosmic; 923185

DR   Cosmic; 1612902

DR   GEO; GSM827521

DR   GEO; GSM1374967

DR   JCRB; JCRB0261

RX   DOI=10.5794/jjoms.36.307;

RX   PubMed=9290701;

RX   PubMed=15885884;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Mandible.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 10,11

ST   D16S539: 9,11

ST   D5S818: 8,10

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3174 ! T.T

SX   Male

CA   Cancer cell line

//

ID   T/C28a2

AC   CVCL_6850

SY   T/C-28a2; TC28a2; C28A2; T/C-28

DR   BTO; BTO:0003860

DR   GEO; GSM297603

DR   GEO; GSM297604

DR   Lonza; 121

DR   Millipore; SCC042

RX   PubMed=7989586;

RX   PubMed=14673991;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   T/C28a4

AC   CVCL_M776

SY   T/C-28a4

DR   BTO; BTO:0005558

RX   PubMed=14673991;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6850 ! T/C28a2

SX   Female

CA   Transformed cell line

//

ID   T/G HA-VSMC

AC   CVCL_4009

SY   T/G HA VSMC; T/G HA-vSMC

DR   BTO; BTO:0001962

DR   CLO; CLO_0009237

DR   CLDB; cl4470

DR   ATCC; CRL-1999

DR   BioSample; SAMN03471275

DR   CCRID; 3142C0001000000058

DR   ECACC; 94102702

DR   IZSLER; BS CL 149

DR   NCBI_Iran; C591

CC   Discontinued: ECACC; 94102702; probable.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 12,13

ST   D7S820: 9,10

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   T02J-10/10

AC   CVCL_U010

SY   CHO-GCGR

DR   ECACC; 10031605

RX   PubMed=21335600;

CC   Transfected with: HGNC; 4192; GCGR.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T02J-7/10

AC   CVCL_U011

SY   CHO-M3; CHO-CHRM3

DR   ECACC; 10031603

RX   PubMed=21335600;

CC   Transfected with: HGNC; 1952; CHRM3.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T02J-9/10

AC   CVCL_U012

SY   CHO-H2; CHO-HRH2

DR   ECACC; 10031604

RX   PubMed=21335600;

CC   Transfected with: HGNC; 5183; HRH2.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T1

AC   CVCL_7904

SY   T1 (174 x CEM.T1); T1(174 x CEM.T1); 174xCEM.T1; 174xCEM; CEMx174; CEM x 174

DR   CLO; CLO_0009238

DR   ATCC; CRL-1991

DR   BioSample; SAMN03471270

DR   NIH-ARP; 272-357

RX   PubMed=3872841;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 10,12

ST   D5S818: 12,14

ST   D7S820: 10,11,15

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6260 ! LCL 721.174

HI   CVCL_7905 ! CEMR.3

CA   Hybrid cell line

//

ID   T1 [Human contaminated neural stem cell]

AC   CVCL_1U15

DR   BioSample; SAMN03151760

RX   PubMed=21814484;

RX   PubMed=22949886;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=22949886).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   T1-73

AC   CVCL_3605

AS   CVCL_1772

SY   TI-73; T173

DR   CLO; CLO_0009241

DR   ATCC; CRL-7943

DR   BioSample; SAMN03471127

DR   CCLE; T173_BONE

DR   ChEMBL-Cells; CHEMBL3308222

DR   ChEMBL-Targets; CHEMBL2366158

DR   Cosmic; 687932

DR   Cosmic; 910696

DR   GDSC; 910696

DR   GEO; GSM185158

DR   GEO; GSM185159

DR   GEO; GSM827271

DR   GEO; GSM887682

DR   GEO; GSM888774

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 8,12

ST   D7S820: 8,10

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_N340 ! F1-73

CA   Cancer cell line

//

ID   T1-A

AC   CVCL_6C57

RX   PubMed=26254261;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5845 ! NIH 3T3-ras

SX   Male

CA   Transformed cell line

//

ID   T1.7

AC   CVCL_K255

DR   CLO; CLO_0050389

DR   RCB; RCB2307

CC   Monoclonal antibody target: UniProtKB; P18266; Rat Gsk3b.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T1/CUHK

AC   CVCL_E317

RX   PubMed=1280031;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T1/HCVcon

AC   CVCL_B334

RX   PubMed=15914852;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7904 ! T1

CA   Hybrid cell line

//

ID   T1/NS3-4A

AC   CVCL_B335

RX   PubMed=15914852;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7904 ! T1

CA   Hybrid cell line

//

ID   T1000

AC   CVCL_M809

RX   PubMed=22911243;

DI   NCIt; C4250; Well differentiated liposarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T101 [Mouse hybridoma against bladder carcinomas]

AC   CVCL_N333

DR   ATCC; HB-8273

RX   Patent=US4643971;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T101 [Mouse hybridoma against human CD5]

AC   CVCL_DC79

DR   ATCC; CRL-8023

RX   CelloPub=CLPUB00335;

RX   Patent=US4675386;

RX   PubMed=6993560;

CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.

CC   Anecdotal: The T101 mAb was one of the earliest mAbs to be tested in clinical trials against cutaneous T cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL).

CC   Discontinued: ATCC; CRL-8023; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T101-iPSC

AC   CVCL_DD61

RX   PubMed=27191603;

ST   Source(s): PubMed=27191603

ST   Amelogenin: X,Y

ST   CSF1PO: 10,14

ST   D13S317: 9,11

ST   D16S539: 12

ST   D21S11: 28,31

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DD53 ! ND31630

SX   Male

CA   Induced pluripotent stem cell

//

ID   T11

AC   CVCL_8926

RX   PubMed=19886054;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T110 [Human B-cell IHW]

AC   CVCL_6G70

DR   IMGT/HLA; 12647

RX   PubMed=11782282;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   T110 [Mouse hybridoma]

AC   CVCL_N334

DR   ATCC; HB-8278

RX   Patent=US4643971;

CC   Discontinued: ATCC; HB-8278; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T1165

AC   CVCL_6731

SY   TEPC 1165

DR   Lonza; 90

RX   PubMed=3261383;

RX   PubMed=3726549;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=T1165

CC   Breed/subspecies: BALB/cAnPt.

DI   NCIt; C21631; Mouse plasmacytoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   T11D7e2

AC   CVCL_F769

SY   T11D7

DR   CLO; CLO_0009239

DR   ATCC; TIB-103

DR   BCRC; 60471

DR   ECACC; 92021209

DR   ECACC; 92021210

RX   PubMed=393521;

CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (allotype 1.1).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T138

AC   CVCL_N335

DR   ATCC; HB-8277

RX   Patent=US4643971;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T14c

AC   CVCL_HF47

RX   PubMed=2583278;

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   T16

AC   CVCL_N336

DR   ATCC; HB-8279

RX   Patent=US4643971;

RX   Patent=US4935344;

CC   Discontinued: ATCC; HB-8279; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T1682

AC   CVCL_D023

DR   GEO; GSM577205

RX   PubMed=18360827;

DI   NCIt; C3411; Thymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T1889

AC   CVCL_D024

SY   TC1889; T-1889

DR   Cosmic; 1498256

DR   GEO; GSM577204

RX   PubMed=18360827;

DI   NCIt; C7569; Thymic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T1P26

AC   CVCL_8333

RX   PubMed=8125107;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8337 ! M4Beu

CA   Cancer cell line

//

ID   T1P26L

AC   CVCL_8334

RX   PubMed=11059782;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8333 ! T1P26

CA   Cancer cell line

//

ID   T1P26R

AC   CVCL_8335

RX   PubMed=11059782;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8333 ! T1P26

CA   Cancer cell line

//

ID   T2

AC   CVCL_2211

SY   T2 (174 x CEM.T2); T2(174 x CEM.T2); 174xCEM.T2; CEMx721.174.T2

DR   BTO; BTO:0003771

DR   CLO; CLO_0009242

DR   CLO; CLO_0050160

DR   ATCC; CRL-1992

DR   BioSample; SAMN03471271

DR   BioSample; SAMN03472034

DR   DSMZ; ACC-598

DR   NCBI_Iran; C509

DR   RCB; RCB1932

DR   TKG; TKG 0599

DR   TOKU-E; 3251

RX   PubMed=1373173;

RX   PubMed=3872841;

CC   Doubling time: ~40-60 hours (DSMZ).

ST   Source(s): ATCC; DSMZ; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 10,12

ST   D5S818: 12,14

ST   D7S820: 10,11,15 (ATCC; DSMZ)

ST   D7S820: 10,11 (RCB; TKG)

ST   TH01: 6,7,9.3

ST   TPOX: 8,12

ST   vWA: 14,17,20 (ATCC; DSMZ; TKG)

ST   vWA: 17,19 (RCB)

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7904 ! T1

CA   Hybrid cell line

//

ID   T2-A

AC   CVCL_6C58

RX   PubMed=26254261;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6C57 ! T1-A

SX   Male

CA   Transformed cell line

//

ID   T2.A3

AC   CVCL_S602

SY   T2-A3; T2/A3

CC   Transfected with: HGNC; 4931; HLA-A (allele HLA-A3).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2211 ! T2

CA   Hybrid cell line

//

ID   T2.DR3

AC   CVCL_9W17

SY   T2/DR3; T2DR3

RX   PubMed=1373173;

RX   PubMed=7600288;

RX   PubMed=8195723;

CC   Transfected with: HGNC; 4948; HLA-DRB1 (allele DRB1*03:01).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2211 ! T2

CA   Hybrid cell line

//

ID   T2.DR3/DM

AC   CVCL_9W18

RX   PubMed=7600288;

CC   Transfected with: HGNC; 4934; HLA-DMA.

CC   Transfected with: HGNC; 4935; HLA-DMB.

CC   Transfected with: HGNC; 4948; HLA-DRB1 (allele DRB1*03:01).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9W17 ! T2.DR3

CA   Hybrid cell line

//

ID   T2.DR4

AC   CVCL_9W15

SY   T2.DR4w4; T2-DR4; T2DR4

DR   NCBI_Iran; C529

RX   PubMed=8195723;

CC   Transfected with: HGNC; 4948; HLA-DRB1 (allele DRB1*04:01).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2211 ! T2

CA   Hybrid cell line

//

ID   T2.DR4/DM

AC   CVCL_9W16

SY   T2-DR4-DM; T2DR4.DM

CC   Transfected with: HGNC; 4934; HLA-DMA.

CC   Transfected with: HGNC; 4935; HLA-DMB.

CC   Transfected with: HGNC; 4948; HLA-DRB1 (allele DRB1*04:01).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9W15 ! T2.DR4

CA   Hybrid cell line

//

ID   T2/CUHK

AC   CVCL_E318

RX   PubMed=1280031;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T201

AC   CVCL_V486

RX   PubMed=11251167;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T21C1

AC   CVCL_1E83

SY   ND50026

DR   NHCDR; ND50026

WW   https://www.nimhgenetics.org/stem_cells/crm_lines.php

CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X867 ! AG06872

SX   Female

CA   Induced pluripotent stem cell

//

ID   T21C5

AC   CVCL_1E84

SY   ND50027

DR   NHCDR; ND50027

WW   https://www.nimhgenetics.org/stem_cells/crm_lines.php

CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.

CC   Characteristics: Lost the third copy of chromosome 21.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X867 ! AG06872

SX   Female

CA   Induced pluripotent stem cell

//

ID   T222

AC   CVCL_S811

DR   ChEMBL-Cells; CHEMBL3307464

DR   ChEMBL-Targets; CHEMBL614947

RX   PubMed=6318979;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T23

AC   CVCL_N337

DR   ATCC; HB-8271

RX   Patent=US4643971;

CC   Discontinued: ATCC; HB-8271; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T235

AC   CVCL_6478

SY   ATC235

DR   Cosmic; 1239957

DR   Cosmic; 2054078

DR   Cosmic; 2186781

RX   PubMed=17406368;

RX   PubMed=18713817;

RX   PubMed=23833040;

ST   Source(s): PubMed=18713817

ST   Amelogenin: X

ST   D13S317: 11,14

ST   D18S51: 13,19

ST   D21S11: 29

ST   D3S1358: 14

ST   D5S818: 9,12

ST   D7S820: 8,10

ST   D8S1179: 11,14

ST   FGA: 21,23

ST   vWA: 17,18

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T238

AC   CVCL_6299

DR   Cosmic; 1239958

DR   Cosmic; 2036696

DR   Cosmic; 2054089

DR   Cosmic; 2186788

RX   PubMed=17406368;

RX   PubMed=18713817;

RX   PubMed=23833040;

ST   Source(s): PubMed=18713817

ST   Amelogenin: X

ST   D13S317: 12

ST   D18S51: 10,17

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 11,13

ST   D8S1179: 12

ST   FGA: 21,22

ST   vWA: 16,17

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T24

AC   CVCL_0554

SY   T-24; T 24

DR   BTO; BTO:0001345

DR   CLO; CLO_0009235

DR   CLO; CLO_0009245

DR   CLO; CLO_0050843

DR   CLO; CLO_0050844

DR   EFO; EFO_0002864

DR   MCCL; MCC:0000455

DR   CLDB; cl4452

DR   ATCC; HTB-4

DR   BCRC; 60062

DR   BCRJ; 0231

DR   BioSample; SAMN03472744

DR   BioSample; SAMN03473324

DR   CCLE; T24_URINARY_TRACT

DR   CCRID; 3111C0001CCC000295

DR   CCRID; 3131C0001000700055

DR   CCRID; 3142C0001000000076

DR   ChEMBL-Cells; CHEMBL3307700

DR   ChEMBL-Targets; CHEMBL614774

DR   CLS; 300352/p619_T24

DR   Cosmic; 716174

DR   Cosmic; 724812

DR   Cosmic; 755400

DR   Cosmic; 845561

DR   Cosmic; 846275

DR   Cosmic; 925832

DR   Cosmic; 928817

DR   Cosmic; 943742

DR   Cosmic; 1001664

DR   Cosmic; 1016880

DR   Cosmic; 1046673

DR   Cosmic; 1285130

DR   Cosmic; 1285985

DR   Cosmic; 1302355

DR   Cosmic; 1927302

DR   Cosmic; 1938698

DR   Cosmic; 2037960

DR   Cosmic; 2050465

DR   Cosmic; 2057459

DR   Cosmic; 2444230

DR   Cosmic-CLP; 724812

DR   DSMZ; ACC-376

DR   GDSC; 724812

DR   GEO; GSM492493

DR   GEO; GSM887683

DR   GEO; GSM888775

DR   GEO; GSM1374940

DR   GEO; GSM1574571

DR   GEO; GSM1670520

DR   JCRB; JCRB0711

DR   KCB; KCB 92027YJ

DR   KCLB; 30004

DR   LINCS; 50048

DR   PRIDE; PXD003105

DR   RCB; RCB0431

DR   RCB; RCB2536

DR   TKG; TKG 0443

DR   TOKU-E; 3252

RX   PubMed=833871;

RX   PubMed=864752;

RX   PubMed=2607719;

RX   PubMed=3708594;

RX   PubMed=4133950;

RX   PubMed=6244232;

RX   PubMed=6823318;

RX   PubMed=6826254;

RX   PubMed=7185004;

RX   PubMed=8873383;

RX   PubMed=9290701;

RX   PubMed=16885334;

RX   PubMed=19375735;

RX   PubMed=22460905;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25997541;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=T24

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-335.html

WW   http://tcpaportal.org/mclp/

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12 (ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; TKG)

ST   CSF1PO: 12 (RCB)

ST   D13S317: 12 (ATCC; CLS; Cosmic-CLP; JCRB; KCLB; RCB; TKG)

ST   D13S317: 9,12 (DSMZ)

ST   D16S539: 9

ST   D18S51: 16,18

ST   D21S11: 29

ST   D3S1358: 16,21 (CLS)

ST   D3S1358: 16 (KCLB)

ST   D5S818: 10,12 (ATCC; CLS; Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=11416159; TKG)

ST   D5S818: 10 (RCB)

ST   D7S820: 10,11

ST   D8S1179: 9,14 (CLS)

ST   D8S1179: 14 (PubMed=11416159)

ST   FGA: 17,22

ST   Penta D: 11,15

ST   Penta E: 7,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17 (ATCC; Cosmic-CLP; JCRB; RCB; TKG)

ST   vWA: 17,19 (CLS; DSMZ; KCLB; PubMed=11416159)

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T24/83

AC   CVCL_2728

DR   CLO; CLO_0009246

DR   CLDB; cl4473

DR   ECACC; 85061107

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   T24/DDP10

AC   CVCL_Y181

DR   CGH-DB; 9115-4

RX   PubMed=8205547;

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   T24/DDP5

AC   CVCL_Y182

DR   CGH-DB; 9113-4

RX   PubMed=8205547;

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   T24/DDP7

AC   CVCL_Y183

DR   CGH-DB; 9114-4

RX   PubMed=8205547;

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   T241

AC   CVCL_M975

SY   ATC241

DR   Cosmic; 1239979

DR   Cosmic; 2054112

DR   Cosmic; 2186784

RX   PubMed=17406368;

RX   PubMed=23833040;

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T243

AC   CVCL_M976

DR   Cosmic; 2186785

RX   PubMed=17406368;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T24T

AC   CVCL_M892

RX   PubMed=10679914;

RX   PubMed=12460916;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   T265

AC   CVCL_S805

SY   T265-2c; T265-2C; T265p21

DR   EFO; EFO_0006304

DR   Cosmic; 1644552

DR   Cosmic; 1801808

DR   Cosmic; 2307730

RX   PubMed=9766530;

RX   PubMed=16429615;

RX   PubMed=16510576;

RX   PubMed=21084276;

RX   PubMed=22346343;

RX   PubMed=24726063;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

DI   NCIt; C3273; Neurofibromatosis type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T26J-1/09

AC   CVCL_U013

SY   CHO-Beta-2; CHO-ADRB2

DR   ECACC; 10031601

RX   PubMed=21335600;

CC   Transfected with: HGNC; 286; ADRB2.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T27A

AC   CVCL_3606

DR   CLO; CLO_0009247

DR   ATCC; TIB-57

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   T27A1

AC   CVCL_AZ72

RX   PubMed=7583324;

RX   PubMed=10516297;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: PVG.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   T29

AC   CVCL_2G67

RX   PubMed=14996724;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5535 ! IOSE-29

SX   Female

CA   Telomerase immortalized cell line

//

ID   T29/33

AC   CVCL_DC80

DR   ATCC; CRL-8036

RX   Patent=US4582797;

RX   PubMed=6968338;

CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.

CC   Discontinued: ATCC; CRL-8036; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4696 ! S194/5.XXO.BU.1

CA   Hybridoma

//

ID   T29H

AC   CVCL_2G69

RX   PubMed=14996724;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2G67 ! T29

SX   Female

CA   Telomerase immortalized cell line

//

ID   T29K

AC   CVCL_2G74

RX   PubMed=14996724;

CC   Transfected with: HGNC; 6407; KRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2G67 ! T29

SX   Female

CA   Telomerase immortalized cell line

//

ID   T3-1C12

AC   CVCL_J130

DR   ATCC; HB-9030

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9030; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-1C9

AC   CVCL_J131

DR   ATCC; HB-9033

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9033; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-1D8

AC   CVCL_J132

DR   ATCC; HB-9032

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9032; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-1E10

AC   CVCL_J133

DR   ATCC; HB-9060

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9060; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-1E5

AC   CVCL_J134

DR   ATCC; HB-9029

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9029; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-1E7

AC   CVCL_J135

DR   ATCC; HB-9055

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9055; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2A9

AC   CVCL_J136

DR   ATCC; HB-9028

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9028; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2B1

AC   CVCL_J137

DR   ATCC; HB-9057

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9057; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2D2

AC   CVCL_J138

DR   ATCC; HB-9061

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9061; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2G4

AC   CVCL_J139

DR   ATCC; HB-9058

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9058; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2H5

AC   CVCL_J140

DR   ATCC; HB-9056

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9056; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-2H6

AC   CVCL_J141

DR   ATCC; HB-9062

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9062; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-3A1

AC   CVCL_F770

SY   3A1

DR   CLO; CLO_0009248

DR   ATCC; HB-2

DR   NCBI_Iran; H158

RX   PubMed=6156457;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   T3-3F11

AC   CVCL_J142

DR   ATCC; HB-9059

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9059; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-3H1

AC   CVCL_J143

DR   ATCC; HB-9064

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9064; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-4A7

AC   CVCL_J144

DR   ATCC; HB-9063

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9063; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-4C11

AC   CVCL_J145

DR   ATCC; HB-9031

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9031; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-5E9

AC   CVCL_G093

SY   5E9C11

DR   CLO; CLO_0001436

DR   ATCC; HB-21

RX   PubMed=6787129;

CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   T3-8B8

AC   CVCL_J146

DR   ATCC; HB-9066

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9066; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-8F5

AC   CVCL_J147

DR   ATCC; HB-9067

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9067; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-9E7

AC   CVCL_J148

DR   ATCC; HB-9065

RX   Patent=US5071759;

CC   Discontinued: ATCC; HB-9065; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T3-HA

AC   CVCL_6C59

RX   PubMed=26254261;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6C58 ! T2-A

SX   Male

CA   Transformed cell line

//

ID   T3-HEP-W1

AC   CVCL_4Z94

RX   DOI=10.2957/kanzo.28.1135;

RX   PubMed=3338696;

DI   NCIt; C124251; Woodchuck hepatocellular carcinoma

OX   NCBI_TaxID=9995; ! Marmota monax

SX   Male

CA   Cancer cell line

//

ID   T34

AC   CVCL_J352

RX   PubMed=3261629;

DI   NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T34-2

AC   CVCL_AZ71

RX   PubMed=7583324;

RX   PubMed=10516297;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CFHB Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   T351

AC   CVCL_M977

DR   Cosmic; 1239980

DR   Cosmic; 2054118

DR   Cosmic; 2186786

RX   PubMed=17406368;

RX   PubMed=23833040;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T35J-5/09

AC   CVCL_U014

SY   CHO-FFAR3

DR   ECACC; 10031602

CC   Transfected with: HGNC; 4499; FFAR3.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   T36274

AC   CVCL_6335

SY   T3 6274

DR   CLO; CLO_0009249

DR   ATCC; CRL-2012

RX   PubMed=2985973;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0361 ! JB6 Cl 30-7b

CA   Transformed cell line

//

ID   T37i

AC   CVCL_S893

RX   PubMed=9502766;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   T3M-1

AC   CVCL_8289

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=308840;

RX   PubMed=2474371;

CC   Doubling time: ~17 hours (PubMed=308840).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8663 ! CJM [Human OCSCC]

SX   Male

CA   Cancer cell line

//

ID   T3M-1 Cl-10

AC   CVCL_8761

SY   T3M-1 Clone10; T3M-1 clone-10

DR   CLO; CLO_0050090

DR   BioSample; SAMN03472203

DR   Cosmic; 2009525

DR   RCB; RCB1017

RX   PubMed=14733907;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 9,12

ST   D5S818: 10,13

ST   D7S820: 12,13

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8289 ! T3M-1

SX   Male

CA   Cancer cell line

//

ID   T3M-1 Cl-2

AC   CVCL_8762

SY   T3M-1 Clone2; T3M-1 clone-2

DR   CLO; CLO_0050091

DR   BioSample; SAMN03472202

DR   RCB; RCB1015

RX   PubMed=14733907;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9,12

ST   D5S818: 10,13

ST   D7S820: 12,13

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8289 ! T3M-1

SX   Male

CA   Cancer cell line

//

ID   T3M-10

AC   CVCL_8067

SY   T3M10

DR   CLO; CLO_0050071

DR   BioSample; SAMN03472206

DR   CCLE; T3M10_LUNG

DR   RCB; RCB1020

RX   PubMed=6088016;

RX   PubMed=6091874;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9,10

ST   D5S818: 11

ST   D7S820: 11,14

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T3M-11

AC   CVCL_8066

SY   T3M11

DR   CLO; CLO_0050046

DR   BioSample; SAMN03472208

DR   RCB; RCB1022

RX   PubMed=6091874;

RX   PubMed=7730145;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 10,13

ST   D5S818: 10,13

ST   D7S820: 8,12

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T3M-12

AC   CVCL_4058

SY   T3M12

DR   CLO; CLO_0050060

DR   BioSample; SAMN03471951

DR   RCB; RCB1019

DR   RCB; RCB2281

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Partially contaminated. Some stocks (such as RCB1019) were contaminated by T3M-1 (PubMed=20143388).

CC   Discontinued: RCB; RCB1019; true.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 13

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T3M-15

AC   CVCL_Y007

RX   PubMed=6091874;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T3M-3

AC   CVCL_8065

SY   T3M3

DR   CLO; CLO_0050641

DR   BioSample; SAMN03472204

DR   RCB; RCB1018

RX   PubMed=6603906;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T3M-4

AC   CVCL_4056

SY   T3M4; Panc89; Panc-89; PANC-89; Panc 89

DR   BTO; BTO:0002864

DR   CLO; CLO_0050113

DR   EFO; EFO_0002714

DR   BioSample; SAMN03472207

DR   CCLE; T3M4_PANCREAS

DR   Cosmic; 710873

DR   Cosmic; 724641

DR   Cosmic; 736281

DR   Cosmic; 922257

DR   Cosmic; 922263

DR   Cosmic; 933528

DR   Cosmic; 2546061

DR   Cosmic; 2546062

DR   GEO; GSM887684

DR   GEO; GSM888776

DR   GEO; GSM1374814

DR   GEO; GSM1374815

DR   GEO; GSM1374816

DR   RCB; RCB1021

RX   PubMed=6821838;

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=22460905;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/T3M-4.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,13

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 18,19,21

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T3M-5

AC   CVCL_8064

SY   T3M5

DR   CLO; CLO_0050948

DR   BioSample; SAMN03472201

DR   Cosmic; 2009526

DR   RCB; RCB1012

RX   PubMed=6982994;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 12,13

ST   D16S539: 10,12

ST   D5S818: 11,13

ST   D7S820: 13

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C46008; Thyroid gland squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T4 clone 3

AC   CVCL_DA07

DR   ATCC; HB-8499

RX   Patent=US4636478;

CC   Monoclonal antibody target: ChEBI; CHEBI:18332; L-thyroxine.

CC   Discontinued: ATCC; HB-8499; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T4 Clone 5 (10-0101, 0062-83)

AC   CVCL_F771

DR   CLO; CLO_0009250

DR   ATCC; HB-8500

RX   Patent=US4636478;

CC   Monoclonal antibody target: ChEBI; CHEBI:18332; L-thyroxine.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   T4-4

AC   CVCL_0E54

RX   PubMed=11904297;

CC   Transfected with: HGNC; 11730; TERT.

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Telomerase immortalized cell line

//

ID   T4-PA

AC   CVCL_6C60

RX   PubMed=26254261;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6C59 ! T3-HA

SX   Male

CA   Transformed cell line

//

ID   T404

AC   CVCL_1T20

DR   BioSample; SAMN03151954

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T19 ! T406 [Human HNSCC]

OI   CVCL_4910 ! Tu 138

OI   CVCL_1T17 ! Tu 158LN

OI   CVCL_4911 ! Tu 159

OI   CVCL_4914 ! Tu 182

OI   CVCL_4915 ! Tu 212

OI   CVCL_1T18 ! Tu 212LN

CA   Cancer cell line

//

ID   T406 [Human glioblastoma]

AC   CVCL_4570

SY   T-406

DR   CLS; 300361/NA

RX   PubMed=3759084;

CC   Discontinued: CLS; 300361; true.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T406 [Human HNSCC]

AC   CVCL_1T19

DR   BioSample; SAMN03151955

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T20 ! T404

OI   CVCL_4910 ! Tu 138

OI   CVCL_1T17 ! Tu 158LN

OI   CVCL_4911 ! Tu 159

OI   CVCL_4914 ! Tu 182

OI   CVCL_4915 ! Tu 212

OI   CVCL_1T18 ! Tu 212LN

CA   Cancer cell line

//

ID   T409

AC   CVCL_1Q88

SY   T-409

DR   BioSample; SAMN03151991

DR   Cosmic; 1530764

RX   PubMed=18234965;

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 12,13

ST   D5S818: 10,13

ST   D7S820: 9,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7707 ! UM-SCC-1

SX   Male

CA   Cancer cell line

//

ID   T43

AC   CVCL_N338

DR   ATCC; HB-8275

RX   Patent=US4643971;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T449

AC   CVCL_M807

SY   93449; LPS449

DR   Cosmic; 2307716

DR   TOKU-E; 4077

RX   PubMed=17354236;

RX   PubMed=22911243;

RX   PubMed=24726063;

DI   NCIt; C4250; Well differentiated liposarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M808 ! T778

SX   Female

CA   Cancer cell line

//

ID   T47D-E2J

AC   CVCL_HG14

SY   T47D E2J; E2J

DR   Ximbio; 153169

RX   PubMed=11118434;

RX   PubMed=16319059;

CC   Transfected with: HGNC; 4203; GCNT1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D-KBluc

AC   CVCL_K229

SY   T47DKBluc; T47DKBLUC

DR   ATCC; CRL-2865

DR   LINCS; 51091

RX   PubMed=15166400;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D-ST3

AC   CVCL_HG15

SY   T47D 3STMYC

RX   PubMed=9182658;

RX   PubMed=16319059;

CC   Transfected with: HGNC; 10862; ST3GAL1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D-ST3-STn

AC   CVCL_HG17

RX   PubMed=16319059;

CC   Transfected with: HGNC; 10862; ST3GAL1.

CC   Transfected with: HGNC; 23614; ST6GALNAC1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_HG15 ! T47D-ST3

SX   Female

CA   Cancer cell line

//

ID   T47D-StN

AC   CVCL_HG16

SY   T47D-E2J-StN

DR   Ximbio; 153170

RX   PubMed=16319059;

CC   Transfected with: HGNC; 4203; GCNT1.

CC   Transfected with: HGNC; 23614; ST6GALNAC1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_HG14 ! T47D-E2J

SX   Female

CA   Cancer cell line

//

ID   T47D-Y

AC   CVCL_1H30

DR   TOKU-E; 3661

RX   PubMed=8033109;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D-YA

AC   CVCL_1H31

RX   PubMed=8033109;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1H30 ! T47D-Y

SX   Female

CA   Cancer cell line

//

ID   T47D-YB

AC   CVCL_1H32

RX   PubMed=8033109;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1H30 ! T47D-Y

SX   Female

CA   Cancer cell line

//

ID   T47D/182R-1

AC   CVCL_1D34

SY   T47D-182R1; 182R-1

DR   Ximbio; 151891

RX   PubMed=24513268;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D46 ! T47D/S5

SX   Female

CA   Cancer cell line

//

ID   T47D/182R-2

AC   CVCL_1D35

SY   T47D-182R2; 182R-2

DR   Ximbio; 151890

RX   PubMed=24513268;

CC   Selected for resistance to: ChEBI; CHEBI:31638; Fulvestrant (ICI 182780).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D46 ! T47D/S5

SX   Female

CA   Cancer cell line

//

ID   T47D/A1-2

AC   CVCL_0I95

SY   T47D(A1-2); A1-2

RX   PubMed=2550815;

CC   Transfected with: RGD; 2741; Nr3c1.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D/S2

AC   CVCL_1D45

DR   ECACC; 16022512

DR   Ximbio; 152109

RX   PubMed=25362855;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 17

ST   D21S11: 28,31

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 23

ST   Penta D: 10,12

ST   Penta E: 7,14

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D/S5

AC   CVCL_1D46

DR   Ximbio; 152111

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D/TR-1

AC   CVCL_1D36

DR   ECACC; 16022513

DR   Ximbio; 152108

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 17

ST   D21S11: 28,31

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 23

ST   Penta D: 10,12

ST   Penta E: 7,14

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D45 ! T47D/S2

SX   Female

CA   Cancer cell line

//

ID   T47D/TR-2

AC   CVCL_1D37

DR   Ximbio; 152110

RX   PubMed=25362855;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1D45 ! T47D/S2

SX   Female

CA   Cancer cell line

//

ID   T47D:A18

AC   CVCL_GY01

SY   A18

RX   PubMed=2224859;

RX   PubMed=8883409;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D:C4

AC   CVCL_GY02

RX   PubMed=2224859;

RX   PubMed=2632259;

RX   PubMed=8883409;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0553 ! T-47D

SX   Female

CA   Cancer cell line

//

ID   T47D:C4:2

AC   CVCL_GY03

SY   T47D:C42; T47DC42; C4:2

DR   TOKU-E; 4085

RX   PubMed=8883409;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_GY02 ! T47D:C4

SX   Female

CA   Cancer cell line

//

ID   T5-1

AC   CVCL_E839

AS   CVCL_H270

SY   T5-1 (3.1.0); T51; T51 LCL

DR   dbMHC; 49031

DR   ECACC; 94071434

DR   IHW; IHW9284

DR   IMGT/HLA; 11419

RX   PubMed=75508;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl284.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   T508

AC   CVCL_W136

RX   PubMed=3759084;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T529-15D3-18-1A3-1B7

AC   CVCL_F773

SY   1B7; 41.6-1B7; CTCC 10752

DR   CLO; CLO_0009252

DR   ATCC; HB-10500

RX   Patent=US5959084;

RX   Patent=US6143873;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F772 ! 443-15D3-2F12

HI   CVCL_J227 ! 3G8 [Mouse hybridoma against human CD16]

CA   Hybridoma

//

ID   T529-15D3-2E5-4G12-1

AC   CVCL_F774

SY   1A7; 34.5-1A7; CTCC 10753

DR   CLO; CLO_0009253

DR   ATCC; HB-10501

RX   Patent=US5959084;

RX   Patent=US6143873;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F772 ! 443-15D3-2F12

HI   CVCL_J227 ! 3G8 [Mouse hybridoma against human CD16]

CA   Hybridoma

//

ID   T560

AC   CVCL_F724

RX   PubMed=1535783;

CC   Breed/subspecies: B10 x B10.H-2aH-4b.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   T56/14

AC   CVCL_DC69

DR   ATCC; CRL-8035

RX   Patent=US4626507;

RX   PubMed=6265934;

CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.

CC   Discontinued: ATCC; CRL-8035; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4696 ! S194/5.XXO.BU.1

CA   Hybridoma

//

ID   T560.1

AC   CVCL_F725

RX   PubMed=1535783;

CC   Breed/subspecies: B10 x B10.H-2aH-4b.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F724 ! T560

CA   Cancer cell line

//

ID   T560.2

AC   CVCL_F726

RX   PubMed=1535783;

CC   Breed/subspecies: B10 x B10.H-2aH-4b.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F724 ! T560

CA   Cancer cell line

//

ID   T560.2.F7

AC   CVCL_F727

RX   PubMed=1535783;

CC   Breed/subspecies: B10 x B10.H-2aH-4b.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F726 ! T560.2

CA   Cancer cell line

//

ID   T560.2.G4

AC   CVCL_F728

RX   PubMed=1535783;

CC   Breed/subspecies: B10 x B10.H-2aH-4b.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F726 ! T560.2

CA   Cancer cell line

//

ID   T567

AC   CVCL_W135

RX   PubMed=3759084;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T61577

AC   CVCL_J123

RX   PubMed=7448785;

CC   Transformant: ChEBI; CHEBI:91112; N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN).

CC   Breed/subspecies: ACI.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   T67

AC   CVCL_M033

RX   PubMed=3485879;

RX   PubMed=7519632;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T7

AC   CVCL_4314

DR   ECACC; 07021402

RX   PubMed=10949996;

CC   Characteristics: Proliferates at permissive temperature (33-35 Celsius) in the presence of IFNG, terminally differentiates at restrictive temperature (39 Celsius) in the absence of IFNG.

CC   Doubling time: 48 hours (ECACC).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   T70

AC   CVCL_M034

RX   PubMed=3485879;

RX   PubMed=7519632;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T705

AC   CVCL_W137

RX   PubMed=3759084;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T7526

AC   CVCL_E840

DR   dbMHC; 49032

DR   ECACC; 94082238

DR   IHW; IHW9076

DR   IMGT/HLA; 11420

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl76.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   T7527

AC   CVCL_E841

DR   dbMHC; 49033

DR   ECACC; 94070716

DR   IHW; IHW9077

DR   IMGT/HLA; 11421

WW   http://bioinformatics.hsanmartino.it/ecbr/cl77.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   T778

AC   CVCL_M808

SY   94778; 778

DR   Cosmic; 2307717

RX   PubMed=17354236;

RX   PubMed=22911243;

RX   PubMed=24726063;

DI   NCIt; C4250; Well differentiated liposarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M807 ! T449

SX   Female

CA   Cancer cell line

//

ID   T78-1

AC   CVCL_X527

SY   V79puro

DR   ChEMBL-Cells; CHEMBL3307256

DR   ChEMBL-Targets; CHEMBL613095

RX   PubMed=9111301;

RX   PubMed=14997211;

CC   Transfected with: UniProtKB; P38489; E.coli nitroreductase nfnB.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   T79-A3

AC   CVCL_X528

SY   V79-NTRpuro

RX   PubMed=9111301;

RX   PubMed=14997211;

CC   Transfected with: UniProtKB; P38489; E.coli nitroreductase nfnB.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   T80

AC   CVCL_2G68

RX   PubMed=14996724;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5546 ! IOSE-80

SX   Female

CA   Telomerase immortalized cell line

//

ID   T80-4

AC   CVCL_5631

RX   PubMed=6504058;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5634 ! Don D-6

SX   Male

CA   Spontaneously immortalized cell line

//

ID   T80-6

AC   CVCL_5632

RX   PubMed=6504058;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5634 ! Don D-6

SX   Male

CA   Spontaneously immortalized cell line

//

ID   T80-7

AC   CVCL_5633

RX   PubMed=6504058;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5634 ! Don D-6

SX   Male

CA   Spontaneously immortalized cell line

//

ID   T80H

AC   CVCL_2G70

RX   PubMed=14996724;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2G68 ! T80

SX   Female

CA   Telomerase immortalized cell line

//

ID   T80K

AC   CVCL_2G75

RX   PubMed=14996724;

CC   Transfected with: HGNC; 6407; KRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2G68 ! T80

SX   Female

CA   Telomerase immortalized cell line

//

ID   T84

AC   CVCL_0555

SY   T-84; T 84

DR   BTO; BTO:0002032

DR   CLO; CLO_0009254

DR   EFO; EFO_0002084

DR   MCCL; MCC:0000456

DR   CLDB; cl4474

DR   CLDB; cl4475

DR   ATCC; CCL-248

DR   BCRC; 60149

DR   BCRJ; 0232

DR   BioSample; SAMN03471378

DR   BioSample; SAMN03473196

DR   CCLE; T84_LARGE_INTESTINE

DR   CCRID; 3111C0001CCC000056

DR   CCRID; 3131C0001001200009

DR   ChEMBL-Cells; CHEMBL3307275

DR   ChEMBL-Targets; CHEMBL613531

DR   CLS; 300354/p479_T84

DR   Cosmic; 887245

DR   Cosmic; 889532

DR   Cosmic; 909761

DR   Cosmic; 983742

DR   Cosmic; 995406

DR   Cosmic; 1043832

DR   Cosmic; 1122335

DR   Cosmic; 1184103

DR   Cosmic; 1187325

DR   Cosmic; 1479590

DR   Cosmic; 1537487

DR   Cosmic; 1609494

DR   Cosmic; 1676743

DR   Cosmic; 1708411

DR   Cosmic; 1803953

DR   Cosmic; 1888953

DR   Cosmic; 2301548

DR   Cosmic; 2302022

DR   Cosmic-CLP; 909761

DR   ECACC; 88021101

DR   GDSC; 909761

DR   GEO; GSM206556

DR   GEO; GSM741255

DR   GEO; GSM827303

DR   GEO; GSM887686

DR   GEO; GSM888778

DR   GEO; GSM1346895

DR   GEO; GSM1374953

DR   GEO; GSM1448090

DR   GEO; GSM1670522

DR   ICLC; HTL95022

DR   IGRhCellID; T84

DR   IZSLER; BS TCL 154

DR   SKY/M-FISH/CGH; 2853

RX   PubMed=2110452;

RX   PubMed=10612807;

RX   PubMed=10737795;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

RX   PubMed=27397505;

WW   http://www.addexbio.com/productdetail?pid=70

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lung.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 10,11

ST   D18S51: 17

ST   D21S11: 31

ST   D3S1358: 19

ST   D5S818: 12

ST   D7S820: 8,10

ST   D8S1179: 15

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 14

ST   TH01: 6,9

ST   TPOX: 8,11 (ATCC; Cosmic-CLP)

ST   TPOX: 8 (CLS; ECACC; PubMed=25877200)

ST   vWA: 17,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T84.66A3.1A.1F2

AC   CVCL_F775

SY   T84.66.A3.1-H-11

DR   CLO; CLO_0009255

DR   ATCC; HB-8747

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   T87

AC   CVCL_N339

DR   ATCC; HB-8274

RX   Patent=US4643971;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   T87/rc

AC   CVCL_M671

RX   PubMed=1692307;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T88-M

AC   CVCL_6542

SY   T88M

DR   CLO; CLO_0051533

DR   RCB; RCB0792

RX   DOI=10.4051/ibc.2010.2.4.0014;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=T88-M

CC   Characteristics: IL3 or IL5 dependent.

CC   Caution: Not from strain DBA/2J as originally published but from strain C3H/He (DOI 10.4051/ibc.2010.2.4.0014).

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5369 ! T-88

SX   Female

CA   Factor-dependent cell line

//

ID   T921

AC   CVCL_T057

RX   PubMed=23813186;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   T95-45D

AC   CVCL_M081

RX   PubMed=12209986;

CC   From: Center for Medical Genetics; Ghent; Belgium.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   T98

AC   CVCL_B368

SY   T-98

RX   PubMed=222778;

RX   PubMed=833871;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   T98G

AC   CVCL_0556

SY   T 98 G; T-98G; T98 G; T98-G

DR   BTO; BTO:0001583

DR   CLO; CLO_0009236

DR   CLO; CLO_0009258

DR   CLO; CLO_0050636

DR   EFO; EFO_0002085

DR   MCCL; MCC:0000457

DR   CLDB; cl4478

DR   CLDB; cl4480

DR   CLDB; cl4481

DR   CLDB; cl4482

DR   ATCC; CRL-1690

DR   BioSample; SAMN01821603

DR   BioSample; SAMN01821719

DR   BioSample; SAMN01821740

DR   BioSample; SAMN03473051

DR   CCLE; T98G_CENTRAL_NERVOUS_SYSTEM

DR   CGH-DB; 154-1

DR   ChEMBL-Cells; CHEMBL3307777

DR   ChEMBL-Targets; CHEMBL614775

DR   Cosmic; 687586

DR   Cosmic; 759898

DR   Cosmic; 849847

DR   Cosmic; 850740

DR   Cosmic; 897444

DR   Cosmic; 1175821

DR   Cosmic; 1217675

DR   Cosmic; 1294953

DR   Cosmic; 1610748

DR   Cosmic; 1746960

DR   Cosmic; 2302325

DR   Cosmic; 2367552

DR   Cosmic; 2491103

DR   Cosmic; 2516040

DR   Cosmic-CLP; 687586

DR   ECACC; 92090213

DR   GDSC; 687586

DR   GEO; GSM326205

DR   GEO; GSM887687

DR   GEO; GSM888779

DR   GEO; GSM1374954

DR   GEO; GSM1670523

DR   IFO; IFO50303

DR   IZSLER; BS TCL 63

DR   JCRB; JCRB9041

DR   KCLB; 21690

DR   PRIDE; PXD000589

DR   PRIDE; PXD002192

DR   RCB; RCB1954

DR   TKG; TKG 0471

RX   PubMed=222778;

RX   PubMed=3413074;

RX   PubMed=11414198;

RX   PubMed=16232199;

RX   PubMed=18445040;

RX   PubMed=19435942;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=25485619;

RX   PubMed=25894527;

RX   PubMed=25984343;

RX   PubMed=26496030;

RX   PubMed=27397505;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-574.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Characteristics: Has no IDH1 mutation.

CC   Doubling time: 40 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Cell surface proteome.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; COG; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=22570425; PubMed=25877200; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 13

ST   D18S51: 13,16

ST   D19S433: 12,13

ST   D21S11: 28,32.2

ST   D2S1338: 19,24

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 21,22 (COG; KCLB)

ST   FGA: 21 (PubMed=22570425; PubMed=25877200)

ST   Penta D: 10,11

ST   Penta E: 16

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17,20

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B368 ! T98

SX   Male

CA   Cancer cell line

//

ID   TA 99

AC   CVCL_F776

SY   TA99

DR   CLO; CLO_0009259

DR   ATCC; HB-8704

RX   Patent=US5160723;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   TA-1

AC   CVCL_F777

DR   CLO; CLO_0009260

DR   ATCC; HB-10206

RX   Patent=US5604107;

CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 101及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。